Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Buemann

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Frontiers in Psychology|January 15, 2024
Does activation of oxytocinergic reward circuits postpone the decline of the aging brain?Benjamin Buemann
Current Aging Science|April 18, 2022
Oxytocin Release: A Remedy for Cerebral InflammagingBenjamin Buemann
Medical Hypotheses|February 8, 2020
Oxytocin may have a therapeutical potential against cardiovascular disease. Possible pharmaceutical and behavioral approachesBenjamin Buemann, Kerstin Uvnäs-Moberg
Ugeskrift for Laeger|October 19, 2004
[Lipogenesis: does it have a relevance in the obesity research?]Benjamin Buemann, Arne V Astrup
Nutrition Research Reviews|December 18, 2008
Alcohol drinking and cardiac riskBenjamin Buemann, Jørn Dyerberg, Arne Astrup
Ugeskrift for Laeger|June 4, 2004
[The sugar report and lipogenesis]Arne Astrup, Søren Toubro, Benjamin Buemann
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 11, 2020
Can intravenous oxytocin infusion counteract hyperinflammation in COVID-19 infected patients?Benjamin Buemann, Donatella Marazziti, Kerstin Uvnäs-Moberg
Clinical Neuropsychiatry|December 15, 2021
Oxytocin, A Possible Treatment for Covid-19? Everything to Gain, Nothing to LosePhuoc-Tan Diep, Benjamin Buemann, Kerstin Uvnäs-Moberg
The Proceedings of the Nutrition Society|July 23, 2002
Low-fat diets and energy balance: how does the evidence stand in 2002?Arne Astrup, Arne Astrup, Benjamin Buemann, et al.
Obesity Research|May 28, 2005
The N363S polymorphism of the glucocorticoid receptor and metabolic syndrome factors in menBenjamin Buemann, Eva Black, Claus Holst, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Psychology|January 15, 2024
Does activation of oxytocinergic reward circuits postpone the decline of the aging brain?Benjamin Buemann
Current Aging Science|April 18, 2022
Oxytocin Release: A Remedy for Cerebral InflammagingBenjamin Buemann
Medical Hypotheses|February 8, 2020
Oxytocin may have a therapeutical potential against cardiovascular disease. Possible pharmaceutical and behavioral approachesBenjamin Buemann, Kerstin Uvnäs-Moberg
Ugeskrift for Laeger|October 19, 2004
[Lipogenesis: does it have a relevance in the obesity research?]Benjamin Buemann, Arne V Astrup
Nutrition Research Reviews|December 18, 2008
Alcohol drinking and cardiac riskBenjamin Buemann, Jørn Dyerberg, Arne Astrup
Ugeskrift for Laeger|June 4, 2004
[The sugar report and lipogenesis]Arne Astrup, Søren Toubro, Benjamin Buemann
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 11, 2020
Can intravenous oxytocin infusion counteract hyperinflammation in COVID-19 infected patients?Benjamin Buemann, Donatella Marazziti, Kerstin Uvnäs-Moberg
Clinical Neuropsychiatry|December 15, 2021
Oxytocin, A Possible Treatment for Covid-19? Everything to Gain, Nothing to LosePhuoc-Tan Diep, Benjamin Buemann, Kerstin Uvnäs-Moberg
The Proceedings of the Nutrition Society|July 23, 2002
Low-fat diets and energy balance: how does the evidence stand in 2002?Arne Astrup, Arne Astrup, Benjamin Buemann, et al.
Obesity Research|May 28, 2005
The N363S polymorphism of the glucocorticoid receptor and metabolic syndrome factors in menBenjamin Buemann, Eva Black, Claus Holst, et al.
Pageof 1